Taysha Gene Therapies grants new hires 384,000 RSUs, options for 92,400 shares under inducement plan
Bitget2026/10/02 12:00- Taysha Gene Therapies granted four new employees 384,000 restricted stock units under its 2023 Inducement Plan.
- Each RSU award vests in four equal annual installments starting on the first anniversary of the vesting commencement date.
- The company also issued options covering 92,400 shares with an exercise price of $4.74.
- Options run for 10 years. Vesting spans four years, with 25% after one year, then monthly over 36 months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Selloff Sends Berkshire to Its Biggest S&P 500 Lead Since 2010: Can It Last?
Meridian weighs $400 million investment decision for Cabaçal mine
Saudi Arabia's oil production in October surged by 26%, reaching the highest level since the onset of the conflict, while Brent crude has dropped over 20% this month
OPEC's monthly report shows that Saudi Arabia's average daily crude oil production in October rose to 10.56 million barrels, just several hundred thousand barrels lower than the pre-war level in February and slightly above its quoted limit under the OPEC framework. Iraq's daily output in October also reached approximately 4.9 million barrels, a new high since the outbreak of war. Meanwhile, after the UAE exited OPEC and began competing in the market independently, both the UAE and Saudi Arabia recently slashed their official December cargo prices for Asian buyers, intensifying the competitive landscape.
Scorpio hits gold beyond Nevada resource
Crypto prices
More
